Provided By Globe Newswire
Last update: Apr 3, 2023
The appointment advances Perspective Therapeutics’ journey to become a global leader in the manufacturing and distribution of therapeutic Cesium-131 brachytherapy radioisotope seeds designed for the treatment of a variety of cancers.